KF
ANGO icon

Kopp Funds’s AngioDynamics ANGO Stock Holding History

Kopp Funds’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$3.14M Buy
+183,220
New +$2.82M 1.42% 21

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kopp Funds's ANGO Position: Q4 2013 in Review

Kopp Funds opened a new position in AngioDynamics (ANGO) in Q4 2013: 183,220 shares worth $3.14M. The stake represents 1.42% of the portfolio and ranks #21 among its holdings.

108 funds tracked by Wall St. Rank hold ANGO as of Q4 2013.

  • Kopp Funds held 183,220 shares of AngioDynamics worth $3.14M as of Q4 2013.
  • AngioDynamics was a new Kopp Funds position in Q4 2013.
  • AngioDynamics made up 1.42% of Kopp Funds's portfolio in Q4 2013, its #21 holding.
  • 108 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2013.

Based on Kopp Funds's 13F filing for Q4 2013, filed 21 Jan 2014.